Celularity (CELU) Non-Current Deferred Tax Liability (2019 - 2026)
Celularity's Non-Current Deferred Tax Liability was $12,000 in Q4 2025, up 33.3% from $9,000 a year earlier and up 33.3% from the prior quarter.
Analysis
Celularity (CELU) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends
From Q2 2019 onward, Celularity has reported Non-Current Deferred Tax Liability for 22 quarters.
- Non-Current Deferred Tax Liability shows a five-year compound annual growth rate of 11.4% (FY2020 to FY2025).
- In earlier years, Non-Current Deferred Tax Liability was $9,000 in FY2024 (unchanged), $9,000 in FY2023 (unchanged), $9,000 in FY2022 (-10.0%) and $10,000 in FY2021 (+42.9%).
- The Q4 2025 figure marks the highest quarterly Non-Current Deferred Tax Liability since Q3 2019.
- Compared with a year earlier, Non-Current Deferred Tax Liability was higher in 1 of the last eight quarters, with growth averaging 4.2%.
- The best year-over-year quarter for Non-Current Deferred Tax Liability over five years was Q3 2021 (growth of 80.4%); the worst was Q4 2022 (a decline of 10.0%).
- Per Business Quant data, CELU's Non-Current Deferred Tax Liability in the three quarters before Q4 2025 was $9,000 (Q3 2025), $9,000 (Q2 2025) and $9,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
API Access
Celularity Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=CELU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();